Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
As CEO, I would not wait six months and I would not let the board delay disclosure while patients remain exposed to an unreported serious risk. I would treat this as a patient-safety, regulatory, legal, and trust crisis—not merely a financial-risk issue. My guiding decisions would be: Patient safety comes first.Read the full answer
Hour-by-Hour Action Plan for the CEO of a Pharmaceutical Company First 24 Hours: Data Validation & Team Mobilization Hours 0–2: Immediate Crisis Team Assembly Action: Convene a crisis team: Chief Medical Officer (CMO), General Counsel (GC), Head of Regulatory Affairs, Chief Communications Officer (CCO), CFO, COO, and…Read the full answer